"Pushing Hands" - And boundaries [MOVIE REVIEW]
“Pushing Hands” was the auspicious start of Ang Lee’s directorial career. Not only was this an accomplished film right out of the gate, but he had already…
Stay updated with breaking news from Lai Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“Pushing Hands” was the auspicious start of Ang Lee’s directorial career. Not only was this an accomplished film right out of the gate, but he had already…
BeiGene has dosed the first subject in a Phase I trial of BGB-23339 being developed to potentially treat multiple immune-mediated disorders.
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--May 19, 2021-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical results and updates from its broad portfolio will be presented at the 2021 Annual Meeting of the American Society of Cancer Oncology (ASCO) being held June 4 â 8, 2021. âWe are pleased to share updates from our growing clinical portfolio across solid tumors and hematologic malignancies at this yearâs ASCO, including multiple novel combinations ...